Matt Dula joins Michael Martin to discuss the inherent risks in the MMJ space and those particular to Cronos Group (NASDAQ: CRON).
More Marijuana posts
Two things you don’t know about marijuana
Does the High Times IPO have more downside than upside?
Study with our Market Wizards
To learn more about our courses and lessons, go to MartinKronicle.com and subscribe at the top of the page. We’ll follow up with you immediately.
Subscribe
